STOCK TITAN

Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
management

Presidio Medical has appointed Richard J. Buchholz to its Board of Directors. Buchholz currently serves as Chief Financial Officer of Inspire Medical Systems (NYSE: INSP), where he has been instrumental in driving strategic financial and operational growth.

With extensive experience in healthcare finance, including previous CFO roles at superDimension and Vascular Solutions, Buchholz brings valuable expertise to Presidio Medical, a clinical stage company developing neuromodulation platforms. The appointment aligns with Presidio's strategy to strengthen its leadership team as it advances through key growth and development stages.

Presidio Medical ha nominato Richard J. Buchholz nel suo Consiglio di Amministrazione. Buchholz attualmente ricopre il ruolo di Chief Financial Officer di Inspire Medical Systems (NYSE: INSP), dove è stato fondamentale per promuovere la crescita strategica finanziaria e operativa.

Con una vasta esperienza nella finanza sanitaria, inclusi i precedenti ruoli di CFO in superDimension e Vascular Solutions, Buchholz porta un prezioso know-how a Presidio Medical, un'azienda in fase clinica che sviluppa piattaforme di neuromodulazione. Questa nomina si allinea con la strategia di Presidio per rafforzare il suo team dirigenziale mentre avanza attraverso fasi chiave di crescita e sviluppo.

Presidio Medical ha nombrado a Richard J. Buchholz en su Junta Directiva. Buchholz actualmente se desempeña como Director Financiero de Inspire Medical Systems (NYSE: INSP), donde ha sido instrumental en impulsar el crecimiento financiero y operativo estratégico.

Con una amplia experiencia en finanzas de salud, incluidos roles anteriores como CFO en superDimension y Vascular Solutions, Buchholz aporta una valiosa experiencia a Presidio Medical, una empresa en etapa clínica que desarrolla plataformas de neuromodulación. La designación está alineada con la estrategia de Presidio para fortalecer su equipo de liderazgo a medida que avanza a través de etapas clave de crecimiento y desarrollo.

Presidio MedicalRichard J. Buchholz를 이사회의 일원으로 임명했습니다. Buchholz는 현재 Inspire Medical Systems (NYSE: INSP)의 최고재무책임자(CFO)로 근무하며 전략적 금융 및 운영 성장 추진에 중요한 역할을 해왔습니다.

의료 재무 분야에서 폭넓은 경험을 보유한 그는 이전에 superDimension 및 Vascular Solutions에서 CFO로 재직한 경력이 있으며, neuromodulation 플랫폼을 개발하는 임상 단계 기업인 Presidio Medical에 귀중한 전문성을 제공합니다. 이번 임명은 Presidio가 주요 성장 및 개발 단계에 진입하는 동안 리더십 팀을 강화하려는 전략과 일치합니다.

Presidio Medical a nommé Richard J. Buchholz au sein de son Conseil d'Administration. Buchholz est actuellement Directeur Financier de Inspire Medical Systems (NYSE: INSP), où il a joué un rôle essentiel dans la promotion de la croissance financière et opérationnelle stratégique.

Avec une vaste expérience dans le secteur financier de la santé, y compris des postes précédents de CFO chez superDimension et Vascular Solutions, Buchholz apporte une expertise précieuse à Presidio Medical, une entreprise en phase clinique développant des plateformes de neuromodulation. Cette nomination s'inscrit dans la stratégie de Presidio visant à renforcer son équipe dirigeante alors qu'elle progresse à travers les principales phases de croissance et de développement.

Presidio Medical hat Richard J. Buchholz in seinen Vorstand berufen. Buchholz ist derzeit Chief Financial Officer von Inspire Medical Systems (NYSE: INSP), wo er eine entscheidende Rolle bei der Förderung des strategischen finanziellen und operativen Wachstums gespielt hat.

Mit umfangreicher Erfahrung im Gesundheitsbereich, einschließlich früherer CFO-Rollen bei superDimension und Vascular Solutions, bringt Buchholz wertvolle Expertise in Presidio Medical, ein klinisches Unternehmen, das Neuromodulationsplattformen entwickelt. Die Ernennung unterstützt die Strategie von Presidio, sein Führungsteam zu stärken, während es sich durch wichtige Wachstums- und Entwicklungsphasen bewegt.

Positive
  • Strategic addition of experienced healthcare CFO to the Board
  • Strengthened financial leadership during clinical development phase
  • Access to expertise from successful medical device commercialization
Negative
  • None.

SAN MATEO, Calif.--(BUSINESS WIRE)-- Presidio Medical, Inc., a clinical stage company developing a transformational neuromodulation platform, is pleased to announce Richard J. Buchholz will join its Board of Directors. Rick is the Chief Financial Officer of Inspire Medical Systems, Inc. (NYSE: INSP), where he has played a pivotal role in driving strategic financial and operational growth for the global leader in the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea.

“We are excited that Rick is joining the Board of Directors of Presidio Medical at this critical time in our company’s journey. His leadership and financial acumen will be instrumental in advancing our vision through key growth and development stages,” said Michael Onuscheck, Chairman and CEO of Presidio Medical.

“I am excited to join the Board as an independent Director and work with the entire team through the next phases of the company’s development,” said Mr. Buchholz. “Presidio Medical’s vision of revolutionizing the way neuromodulation balances the human nervous system – enabling people to live their best life, aligns with my passion for bringing innovative technologies to market that could profoundly impact patient care.”

Since 2014, Mr. Buchholz has served as the Chief Financial Officer of Inspire Medical Systems, Inc. Prior to joining Inspire, Mr. Buchholz served as the Chief Financial Officer at superDimension, Ltd. from 2006 through its acquisition by Covidien plc in 2013. Mr. Buchholz also served as the Chief Financial Officer of Vascular Solutions, Inc., which was acquired by Teleflex Incorporated. Mr. Buchholz holds a B.B.A. from the University of Wisconsin, Eau Claire and is a Certified Public Accountant (inactive).

Rick’s appointment to the Board of Directors reflects Presidio Medical’s commitment to attracting top-tier leadership to drive its strategic objectives and accelerate the adoption of its innovative solutions in healthcare.

About Presidio Medical

Presidio Medical was founded in 2017 and is headquartered in San Mateo, CA. The clinical stage privately held medical device company is developing a transformational neuromodulation platform to treat diseases of undesired neural activity with a first indication in the treatment of chronic pain. Presidio’s investors include Deerfield Management, Invus Opportunities, Action Potential Venture Capital, and ShangBay Capital. For more information, visit www.presidiomedical.com.

Media Contact:

Katherine Neuenfeldt

Presidio Medical, Inc.

media@presidiomedical.com

650-502-1071

Source: Presidio Medical

FAQ

Who is Richard J. Buchholz and what is his role at Inspire Medical Systems (INSP)?

Richard J. Buchholz is the Chief Financial Officer of Inspire Medical Systems (INSP) since 2014, where he leads strategic financial and operational growth initiatives.

What is Richard J. Buchholz's previous experience in healthcare companies?

Buchholz previously served as CFO at superDimension until its acquisition by Covidien in 2013, and as CFO at Vascular Solutions until its acquisition by Teleflex.

What is Presidio Medical's current development stage and focus?

Presidio Medical is a clinical stage company developing a transformational neuromodulation platform aimed at balancing the human nervous system.

Inspire Medical Systems, Inc.

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Stock Data

5.56B
29.36M
1.95%
115.29%
7.48%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
GOLDEN VALLEY